Misinformation, Lack of Access and Confusion Hamper the...
Philip Morris International Inc. (PMI) (NYSE:PM) today released a white paper titled “Unsmoke: Clearing the Way for Change” based on findings from a major international study conducted for the company by independent research firm Povaddo. There is no question that, while the"...
Read More >Dermatologists discuss adverse drug reactions
SALALAH, August 17 – Adverse drug reactions (ADR) drew attention of the dermatologists who gathered in Salalah from all over the GCC to attend first Salalah Dermatology Forum at Salalah Millennium Resort on Saturday. The event opened under the auspices of Dr Ahmed bin Mohammed al"...
Read More >Interventional Cardiologist successfully performs a rare...
Amna, a 43-year-old female started experiencing poor vision in her right eye a few weeks prior to evaluation. Being a diabetic, she decided to seek medical attention and possible intervention by an expert. On visiting Emirates Hospital - Jumeirah (EHJ), an Emirates Healthcare Company and"...
Read More >2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg...
The Edogawa NICHE Committee today announced that the 2019-Edogawa NICHE Prize (www.edogawanicheprize.org) has been awarded to Dr. Steven A. Rosenberg, for his pioneering work in developing effective adoptive immunotherapies and genetically modified T cells which has heralded the birth of a new chapter in the fight against cancer. Dr. Rosenberg’s accomplishment has significantly contributed to the development of several immune system-based drugs and clinically effective immunotherapies including the CAR-T cell therapy. Dr. Rosenberg is an epitome of significance of inter-disciplinary interaction in developing clinical solutions, who after......
Read More >AHF Applauds Appointment of Winnie Byanyima as Head of UNAIDS...
AHF lauded today a historic decision by the United Nations Secretary-General to appoint Winnie Byanyima as the new Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS). Byanyima, who is a prominent Ugandan diplomat and humanitarian, will be the first woman Executive"...
Read More >Concept Medical Granted “Breakthrough Device Designation”...
Concept Medical Inc. (CMI) has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK). Concept Medical Inc. is backed by cardiologist, philanthropist and serial entrepreneur Dr. Kiran Patel, a staunch supporter of innovative and disruptive medical devices, providing breakthrough treatments to the people of the world. Under the leadership of drug delivery pioneer Dr. Manish Doshi, the company has initiated an extensive range......
Read More >Emirates Hospital- Jumeirah, among five hospitals in the...
Emirates Hospital - Jumeirah was recently awarded the Collaboration of Organised and Recognised Endoscopy units (CORE) certificate by the World Endoscopy Organisation (WEO). Only five hospitals in the entire region received this recognition.
Through"...
Read More >UAE efforts continue to curb cholera epidemic in Yemen
ADEN, 9th August, 2019 (WAM) -- The UAE has continued its efforts to curb the spread of cholera in Yemen.
The Emirates Red Crescent, ERC, provided medicinal and medical supplies to hospitals, health centres and"...
Read More >Study Demonstrates Reduction in Mortality Using Masimo Noninvasive,...
Masimo (NASDAQ: MASI) announced today that in a study published in the Journal of Clinical Monitoring and Computing, researchers investigated the effects of implementing a hospital-wide fluid and blood administration protocol using two Masimo measurements: noninvasive, continuous hemoglobin (SpHb®) and pleth variability index (PVi®).1 To evaluate the impact of the implementation, they collected data on transfusions and mortality 30 and 90 days after surgery and compared the findings between two 11-month periods in 2013 and 2014. In the study, Dr. Jérôme Cros, Prof. Nathalie Nathan, and colleagues at Hôpital Dupuytren,......
Read More >SpeeDx Pty. Ltd. Raises $15 Million From U.S. Investment...
SpeeDx Pty. Ltd., the developer of transformative new molecular diagnostic solutions, today announced it had raised up to US $10 million in additional equity investment from US-based Northpond Ventures. This follows an original investment of US $5 million from Northpond Ventures in April"...
Read More >
